Sodium-Glucose Cotransporter 2 Inhibitors as Emerging Anticancer Agents

作者
Yun Kyung Cho,Chang Hee Jung
出处
期刊:Diabetes & Metabolism Journal [Korean Diabetes Association]
卷期号:50 (1): 1-18 被引量:2
标识
DOI:10.4093/dmj.2025.0964
摘要

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are established treatments for type 2 diabetes mellitus, heart failure, and chronic kidney disease, with well-documented metabolic and cardiorenal benefits. Emerging evidence indicates that these agents may also exert anticancer effects through mechanisms independent of glucose lowering. Preclinical studies have demonstrated functional SGLT2 expression in tumors such as prostate, pancreatic, breast, colorectal, and bone cancers. Inhibition of SGLT2 decreases tumor glucose uptake, disrupts mitochondrial respiration with subsequent adenosine monophosphate-activated protein kinase activation, and induces endoplasmic reticulum stress and autophagy. Immunomodulatory effects, including programmed death-ligand 1 (PD-L1) degradation and stimulator of interferon genes (STING)-interferon regulatory factor 3 (IRF3)-interferon-β (IFN-β) pathway activation, further illustrate their pleiotropic effects. Observational cohort studies, particularly from nationwide Korean databases, report reduced risks of pancreatic and prostate cancer among new users of SGLT2 inhibitors. In contrast, randomized controlled trials and meta-analyses focused on cardiovascular outcomes demonstrate neutral effects on overall cancer risk, providing reassurance regarding safety. Early translational studies suggest that combining SGLT2 inhibitors with chemotherapy is feasible and tolerable. In this review, we summarize the biological rationale and mechanistic insights underlying the anticancer effects of SGLT2 inhibitors, highlight preclinical and clinical evidence across different cancer types, and discuss challenges and future directions for their integration into oncology.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
2秒前
冷酷的蓝莓完成签到 ,获得积分10
2秒前
2秒前
双shuang发布了新的文献求助10
2秒前
3秒前
碧蓝白玉发布了新的文献求助20
3秒前
3秒前
3秒前
3秒前
3秒前
岳晓彤发布了新的文献求助10
4秒前
nabo完成签到,获得积分10
4秒前
Oliver完成签到,获得积分10
5秒前
li074完成签到,获得积分10
5秒前
5秒前
tangtang完成签到,获得积分10
5秒前
5秒前
风野云发布了新的文献求助10
6秒前
kermitds完成签到 ,获得积分0
6秒前
情怀的应助被ayan采纳,获得10
7秒前
wlomics26完成签到,获得积分10
7秒前
欧文小骚爷完成签到,获得积分10
8秒前
赘婿的应助被xiaole采纳,获得10
8秒前
Jasper的应助被xx采纳,获得10
9秒前
9秒前
wang完成签到,获得积分10
9秒前
9秒前
9秒前
9秒前
9秒前
9秒前
morena的应助被孤独梦曼采纳,获得10
10秒前
斯文败类的应助被倩2026采纳,获得10
10秒前
momoko发布了新的文献求助10
10秒前
酷波er的应助被qq采纳,获得10
10秒前
晨曦完成签到 ,获得积分10
10秒前
碧蓝白玉完成签到,获得积分20
11秒前
ninininini完成签到 ,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817